In a report released today, Matt Miksic from Barclays reiterated a Buy rating on Medtronic (MDT – Research Report), with a price target ...
Medical device giant Medtronic was hit with three lawsuits in the District of Delaware on Nov. 12—two by the previous ...
The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...
Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...
In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report).
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal ...
The latest trading day saw Medtronic (MDT) settling at $87.72, representing a -0.45% change from its previous close.